Scoping review maps mental-health exposures, including cannabis, but not…

The role of the exposome in mental disorders: a scoping review.

Environmental research • • Review • Related
🤖

AI Summary

This scoping review mapped research on how multiple environmental exposures across a person’s life relate to mental health outcomes. It included 99 studies selected from 13,937 records; most were cohort studies, with cross-sectional and case-control studies also represented. The review covered 22 mental health outcomes, most often depressive-related conditions and psychotic spectrum disorders.

Childhood adversity was the most commonly studied exposure across several diagnostic groups. Cannabis use and features of the built environment were also among the more frequently examined exposures in other mental health outcomes. The review describes a varied set of analytical methods, but concludes that exposome research faces challenges in interpreting findings, establishing causality, and applying results to public health. As a review of existing studies, it does not establish that cannabis causes or prevents mental disorders; this summary is based on the abstract.

💡 Key Findings

1
The scoping review included 99 studies addressing exposome relationships with mental health across 22 outcomes.
High
95%
2
Childhood adversities were the most commonly studied exposures across several mental health condition groups; cannabis use and built-environment characteristics were also commonly examined in other outcomes.
High
90%
3
The review identifies ongoing challenges in interpretability, causality, and public health applicability; it cannot show that cannabis causes or prevents mental disorders.
High
95%

📄 Original Abstract

INTRODUCTION: Previous studies on mental disorders aetiology have traditionally focused on genetics or on single environmental exposures assessed in isolation. However, mental health outcomes arise from the dynamic and cumulative interaction of multiple environmental influences across the life course. Conceptualizing and analyzing these exposures within an exposome framework can improve the understanding of variability across the mental disorder's spectrum. This review aims to map current evidence on the relationship between the exposome and mental health outcomes, highlighting methodological approaches and existing gaps. METHODS: Following the Joanna Briggs Institute methodology, we performed a systematic search conducted across Medline, Scopus, Embase, CINAHL, and PsycInfo. Two reviewers independently screened by titles/abstracts and full texts, extracted data, and synthesized the main findings. Mental health outcomes were classified following DSM-5 criteria. RESULTS: A total of 13,937 records were screened by title and abstract, and 99 of 222 full-text articles met the inclusion criteria. Most studies were cohort designs (n= 54, 55%), followed by cross-sectional (n=32, 32%), and case-control studies (n= 13, 13%). We identified twenty-two mental health outcomes, with several studies assessing more than one. The most frequent were depressive-related conditions (n= 32, 32%) and psychotic spectrum disorders (n= 28, 28%). Childhood adversities (e.g., physical, sexual abuse, bullying) were the most common studied exposures in anxiety, depressive, bipolar, obsessive-compulsive, psychotic spectrum, and personality-related conditions. Cannabis use and characteristics of the built environment were the next most commonly examined in other mental health outcomes. The majority of studies applied an exposome-wide association study approach (n=20, 20%) and unsupervised machine learning methods (n=20, 20%), followed by supervised machine learning (n=17, 17%). CONCLUSIONS: Exposome-based research on mental health remains methodologically challenging. Critical gaps persist regarding interpretability, causality, and public health applicability. Future studies should account for mental disorder phenotypes and integrate multi-omics approaches to advance exposome-informed mental health research.

Explore More Research

Stay informed about the latest cannabis science.

Your stash, decoded.